# Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

> **NCT00318318** · PHASE1 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 20 (actual)

## Conditions studied

- Healthy
- Estrogen Replacement Therapy

## Interventions

- **DRUG:** Premarin

## Key facts

- **NCT ID:** NCT00318318
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-12
- **Final completion:** 2007-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318318, "Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00318318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*